Amicus Therapeutics
FOLD
#3210
Rank
โ‚น428.29 B
Marketcap
โ‚น1,364
Share price
-0.14%
Change (1 day)
85.95%
Change (1 year)

Revenue for Amicus Therapeutics (FOLD)

Revenue in 2025 (TTM): โ‚น55.60 Billion

According to Amicus Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น60.03 Billion. an increase over the revenue in the year 2024 that were of โ‚น45.32 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amicus Therapeutics from 2008 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น56.93 B25.62%
2024 โ‚น45.32 B36.32%
2023 โ‚น33.24 B22.03%
2022 โ‚น27.24 B19.81%
2021 โ‚น22.73 B19.18%
2020 โ‚น19.07 B46.82%
2019 โ‚น12.99 B103.69%
2018 โ‚น6.38 B170.57%
2017 โ‚น2.35 B599.87%
2016 โ‚น0.33 B
2015 N/A-100%
2014 โ‚น77.57 M245.91%
2013 โ‚น22.42 M-97.78%
2012 โ‚น1.00 B-11.09%
2011 โ‚น1.13 B2644.44%
2010 โ‚น41.31 M-98.62%
2009 โ‚น2.98 B315.15%
2008 โ‚น0.71 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novo Nordisk
NVO
โ‚น4.515 T 7,421.82%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
โ‚น936.20 B 1,459.51%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น4.143 T 6,801.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
โ‚น6.70 B-88.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น28.75 B-52.10%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น304.91 B 407.92%๐Ÿ‡บ๐Ÿ‡ธ USA